Published in Am J Nephrol on June 15, 2004
Diabetic kidney disease: from physiology to therapeutics. J Physiol (2014) 1.10
Inflammatory cytokines in diabetic nephropathy. J Diabetes Res (2015) 1.01
Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes (2012) 1.00
Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells. Am J Physiol Regul Integr Comp Physiol (2010) 1.00
Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury. Kidney Int (2015) 0.97
Inflammation in diabetic kidney disease. World J Diabetes (2014) 0.91
Enhanced expression of naofen in kidney of streptozotocin-induced diabetic rats: possible correlation to apoptosis of tubular epithelial cells. Clin Exp Nephrol (2010) 0.91
TNF-α mediates increased susceptibility to ischemic AKI in diabetes. Am J Physiol Renal Physiol (2013) 0.88
Microinflammation in the pathogenesis of diabetic nephropathy. J Diabetes Investig (2013) 0.86
Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase. J Inflamm (Lond) (2015) 0.80
Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications? Vasc Health Risk Manag (2008) 0.79
6. Diabetic Nephropathy. EJIFCC (2009) 0.77
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets. J Diabetes Res (2015) 0.77
Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure. Indian J Pharmacol (2015) 0.75
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am J Physiol Renal Physiol (2002) 1.09